Skip to main content
. 2018 Nov 1;17(1):1019–1029. doi: 10.3892/ol.2018.9656

Figure 2.

Figure 2.

Galectin protein levels in patients with CLL and chromosomal abnormalities. Concentration of (A) Gal-9 in patients with CLL with del(11q) and del (17p). (B) Protein levels of Gal-1 and (C) Gal-9 in patients with CLL with del (11q). (D) Protein levels of Gal-9 in patients with CLL with del(13q) were measured. Data are presented as the mean ± standard error of the mean. Low-risk and normal-risk CLL (n=32), high-risk CLL (n=16). Differences between two groups were analyzed using paired student's t-test. *P<0.05 and ***P<0.0001. CLL, chronic lymphocytic leukemia; Gal, galectin.